efficient light-emitting diodes (LEDs) and control treatment	baseline	time of sleep end	22426	22738	The time of sleep end was earlier in the first week of treatment than in the baseline week in both active and control groups (within-group difference significant at p < 0.0001 and p = 0.047, respectively, paired t test), presumably reflecting the need to complete treatment by 8 A.M. as required by the protocol.
efficient light-emitting diodes (LEDs)	control treatment	amount of remission of Seasonal Affective Disorder (SAD)	1574	1705	At trial end, the proportions of participants in remission (SIGH-SAD less than 9) were significantly greater (Fisher's exact test),
efficient light-emitting diodes (LEDs) and control treatment	baseline	time of sleep end	22426	22629	The time of sleep end was earlier in the first week of treatment than in the baseline week in both active and control groups (within-group difference significant at p < 0.0001 and p = 0.047, respectively
efficient light-emitting diodes (LEDs)	control treatment	amount of remission of Seasonal Affective Disorder (SAD)	20119	20379	The proportion of participants achieving remission was also significantly greater with active than control treatment in the OC analysis of all randomized participants: 57.1% versus 11.1%, p = 0.040 (Fisher's exact test; remission defined as SIGH-SAD score <9).
